The Diary Of A CEO with Steven Bartlett cover image

Ozempic Expert: Ozempic Increases This Disease By A Factor Of 9! They're Lying To You About Ozempic Side Effects & What It's Doing To Our Brains! - Johann Hari

The Diary Of A CEO with Steven Bartlett

00:00

Exploring Semaglutide and Weight Loss Drugs: A Revolutionary Approach

Semaglutide, a drug with GLP1 agonist effect, has various brands - Zempix for diabetes and Wargovi for obesity, which are identical drugs but marketed differently. The drug causes significant weight loss: Zempix produces an average of 15%, Mingero 21%, and Triple G 24.2%. Mingero and Triple G work on multiple gut hormones, enhancing weight loss. Scientists describe these drugs as revolutionary, likening the discovery to finding the Holy Grail or cracking open a treasure chest, revolutionizing weight control by targeting gut hormones.

Play episode from 01:15:44
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app